XIII.8

8. Polydextrose

Synthetic glucose-polymer fiber — high tolerance (50 g/day), low FODMAP, moderate bifidogenic effect.

Latin: synthetic glucose polymer (Litesse®, Sta-Lite®)FODMAP: 🟢 lowEvidence: ★ ★ ★Microbiota: Moderate bifidogenic, high GI tolerance

Polydextrose in 1 minute

What does it provide? A synthetic, partially branched glucose polymer (average DP 12) produced from glucose, sorbitol, and citric acid by heat-catalyzed polymerization (Pfizer 1981 patent). Minimally absorbed in the small intestine, slowly and partially fermented in the colon — moderate bifidogenic effect with low gas profile. Outstanding tolerance: 50 g/day acute dose well tolerated in adults (the highest tolerance threshold among commercial fiber supplements). Caloric content: 1 kcal/g (food-industry standard).

How much? Functional food additive: 4–12 g/serving. Standalone supplement: 8–12 g/day starting range, acute tolerance up to 50 g/day. Bifidogenic effect in human RCTs at 8–12 g/day was the typical dose (Costabile 2012 Br J Nutr).

When to avoid? Severe sorbitol intolerance (small sorbitol residue may remain from production), severe fructose malabsorption (sorbitol cross-reactivity), active UC/Crohn's flare (relative caution), strong soluble-fiber sensitivity (rare), very high acute dose (> 50–90 g at once — osmotic diarrhea threshold).

📜 Historical Overview

Polydextrose was patented in 1981 by Pfizer (Rennhard patent, with US Patent 3,766,165 as precursor) as a carbohydrate-replacing, low-calorie bulking agent. The process: D-glucose (about 90%), sorbitol (about 10%), and catalytic amounts of citric acid are heated under vacuum — the product is a branched, randomly polymerized glucose mixture (DP 2–120, average DP 12). Polydextrose was originally introduced as a sugar substitute in dietary products (light sodas, light biscuits, sugar-free chocolates).

The FDA recognized it in 1981 (21 CFR 172.841), and the EU approved it in 1986 (as additive E1200). In the 2000s, the scientific community rediscovered its fiber function: Hengst 2009 Int J Food Sci Nutr RCT demonstrated bifidogenic effect, Jie 2000 AJCN and Forssten 2014 Int J Food Sci Nutr documented SCFA production and lipid modulation. The FDA formally recognized it as "dietary fiber" in 2016 in the new Nutrition Facts panel regulation (21 CFR 101.9); EFSA 2017 (E 1200 re-evaluation) reaffirmed the safety profile. Today polydextrose is one of the global food industry's main functional fiber additives — particularly as performance enhancer in baked goods, yogurts, "high-fiber" snacks, and "low-calorie" beverages.

Scientific Background

Polydextrose is a synthetic, soluble, partially branched glucose polymer with average degree of polymerization (DP) ≈ 12 (distribution DP 2–120). During production, glucose forms a randomly branched (α-1,6, α-1,2, α-1,3, β-1,6) polymer matrix — so human digestive enzymes (amylase, glucosidases) essentially do NOT break it down. The remainder (1–2%) sorbitol and citric acid stays as end-chain capping groups. Colonic fermentation is slow and PARTIAL (≈ 50–60% colonic fermentation, ≈ 30% excreted unchanged in feces), resulting in a mild gas profile and exceptionally high tolerance.

Caloric content — standardized value. The official caloric content of polydextrose is 1 kcal/g (FDA, EFSA, Codex Alimentarius — accounting for partial fermentation and minor carbohydrate absorption). This is ¼ of normal carbohydrate (4 kcal/g) energy — hence "low-calorie bulking agent."

Microbiome effect — RCT evidence. Costabile A et al. Br J Nutr 2012;108(3):471–481 (double-blind, crossover, placebo-controlled feeding study) in healthy adults: 8 g/day polydextrose for 21 days significantly raised Bifidobacterium and reduced Bacteroides proportion.[2153] Hengst C et al. Int J Food Sci Nutr 2009;60(Suppl 5):96–105 and Forssten 2014 Int J Food Sci Nutr in additional RCTs showed similar bifidogenic effect and elevated fecal SCFA production.[2154][2155] The bifidogenic effect is MODERATE (smaller than FOS/inulin), BUT GI tolerance is SUBSTANTIALLY HIGHER.

GI tolerance — outstanding. Flood MT, Auerbach MH, Craig SAS. Food Chem Toxicol 2004;42(9):1531–1542 review of clinical tolerance studies of polydextrose: healthy adults tolerated 50 g/day acute dose without uncomfortable symptoms.[2156][2157] The typical laxative threshold (osmotic diarrhea) is around 90 g/day — EXTREMELY high, well above FOS (15 g) or inulin (20 g) thresholds.

Glycemia and body weight. Polydextrose glycemic index ≈ 7 (essentially 0). Konig 2012 Nutr J premeal polydextrose supplement (12 g) reduced postprandial glucose peak.[2158] Astbury NM et al. Br J Nutr 2014;111(8):1499–1505 RCT showed premeal polydextrose dose-dependently reduced the next ad libitum meal's energy intake — small satiety-enhancing effect.[2159]

Lipid profile. Jie 2000 AJCN RCT in hypercholesterolemic patients: 12 g/day polydextrose for 4 weeks produced mild LDL reduction. Effect size smaller than oat beta-glucan or psyllium — moderate.

FODMAP status. Monash low FODMAP — well tolerated in IBS at normal dietary doses. High dose (> 30 g/day), however, can trigger osmotic effect.

Regulatory status. FDA: 21 CFR 172.841 (additive), 21 CFR 101.9 (dietary fiber recognition, 2016).[2161] EU: E1200 additive (1986); EFSA ANS Panel "Re-evaluation of polydextrose (E 1200) as a food additive." EFSA Journal 2017;15(1):4544 reaffirmed the safety profile and fiber classification.[2160] Codex Alimentarius: recognized fiber.

✅ Combine with

+ Functional yogurt, smoothie, coffee: taste-neutral, mixable soluble powder.
+ Other soluble fibers (psyllium, beta-glucan): broader SCFA profile.
+ Sugar substitution in diet baked goods: industry kitchen standard.
+ 15–30 minutes before a meal: satiety enhancement (Saetner 2010).
+ IBS low FODMAP diet (Monash): accepted fiber replacement.
+ Ample fluid: general fiber rule.

🚫 Avoid combining with

High-dose sorbitol-containing foods (sugar-free gum, polyol mix) simultaneously: cumulative osmotic load.
Abrupt start at 30+ g/day without titration: mild osmotic diarrhea.
Other high-FODMAP fiber at high doses simultaneously (FOS + GOS + polydextrose): cumulative fermentation, although polydextrose is low FODMAP.
Large dose (> 50 g acute) of "sugar-free" sweets with polydextrose: diarrhea threshold.
"Fiber blend" with sugar additive: worsens metabolic profile.

⚠️ When to avoid — condition-specific

Severe sorbitol intolerance: due to small sorbitol residue.
Severe fructose malabsorption: sorbitol cross-reactivity.
Active UC/Crohn's flare: relative caution (generally tolerated, but medical judgment).
Severe dysphagia: powder dissolves rapidly — lower choking risk than psyllium.
Infants < 1 year: no established safety data.
Severe renal failure: generally fine, moderate dose.
Recent bowel surgery: medical clearance.
Very high acute dose (> 50 g): osmotic diarrhea threshold is individual.
Acute abdominal complaints of unknown cause: avoid until workup.

❌ Myths and their refutation

"Polydextrose is not a real fiber because it's synthetic."MYTH. FDA officially recognized it as "dietary fiber" in 2016 (21 CFR 101.9); EFSA and Codex Alimentarius also classify it as fiber. The "synthetic" label does not exclude fiber function — human digestive enzymes do not break it down, it is partly fermented in the colon, and its bifidogenic effect is documented.

"Polydextrose does not ferment."MYTH. ≈ 50–60% colonic fermentation (Forssten 2014), triggers SCFA production and bifidogenic effect — though SLOWLY and PARTIALLY. This explains the exceptionally high GI tolerance.

"Polydextrose is sugar."MYTH. Built from glucose monomers, but the random branched polymer matrix is NOT broken down by the small intestine. Glycemic index ≈ 7 (essentially 0), caloric content 1 kcal/g (FDA, EFSA standard) — does not behave as carbohydrate.

"The sorbitol content gives everyone diarrhea."MYTH. Residual sorbitol content is 1–2%; an acute 50 g polydextrose dose contains ≈ 0.5–1 g sorbitol — below the typical daily sorbitol tolerance threshold (5–10 g). Exception: severe sorbitol intolerance.

"Polydextrose is the best of fiber supplements."PARTLY MYTH. Polydextrose's strength is its outstanding tolerance and low FODMAP — but the bifidogenic effect is MODERATE (FOS/inulin stronger), and it lacks an EFSA-recognized LDL claim (oat beta-glucan, psyllium stronger). Choice depends on indication.

"Polydextrose is calorie-free."MYTH. 1 kcal/g (FDA, EFSA, Codex standard). Compared to sugar (4 kcal/g) it is SUBSTANTIALLY low-calorie, but not zero.

"Polydextrose is synthetic, therefore harmful to safety."MYTH. > 40 years of market experience, FDA/EFSA/Codex recognition, numerous RCT safety studies. The safety profile is excellent.

References

[2153] Costabile A et al. Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects2012;108(3):471–481. Br J Nutr. Link

In this placebo-controlled, double-blind, crossover human feeding study, the effects of polydextrose (PDX; 8 g/d) on the colonic microbial composition, immune parameters, bowel habits and quality of life were investigated. PDX is a complex glucose oligomer used as a sugar replacer. The main goal of the present study was to identify the microbial groups affected by PDX fermentation in the colon. PDX was shown to significantly increase the known butyrate producer Ruminococcus intestinalis and bacteria of the Clostridium clusters I, II and IV. Of the other microbial groups investigated, decreases in the faecal Lactobacillus-Enterococcus group were demonstrated. Denaturing gel gradient electrophoresis analysis showed that bacterial profiles between PDX and placebo treatments were significantly different.

[2154] Hengst C et al. Effects of polydextrose supplementation on intestinal microbiota and short-chain fatty acid production in healthy adults2009;60(Suppl 5):96–105. Int J Food Sci Nutr. Link

Study in healthy adults on the effects of polydextrose supplementation on the intestinal microbiota and short-chain fatty acid production.

[2155] Forssten SD et al. Influence of a probiotic combination on faecal bifidobacteria — polydextrose effect2014. Int J Food Sci Nutr. Link

Research article examining the influence of a probiotic combination on faecal bifidobacteria, including the polydextrose effect.

[2156] Flood MT, Auerbach MH, Craig SAS. A review of the clinical toleration studies of polydextrose in food2004;42(9):1531–1542. Food Chem Toxicol. Link

Polydextrose is a non-digestible 1 kcal/g polysaccharide used primarily as a sugar replacer and dietary fiber in foods. At typical use levels, polydextrose provides physiological effects similar to those of other dietary fibers. However, excessive consumption of non-digestible carbohydrates can lead to gastrointestinal distress. Nine clinical studies were conducted with polydextrose to evaluate the extent of such symptoms. These studies determined laxation endpoints in adults and children, and showed that polydextrose was better tolerated than most other low digestible carbohydrates (e.g. polyols). This is because of a higher molecular weight and partial colonic fermentation, leading to a lower risk of osmotic diarrhea.

[2157] Jie Z et al. Studies on the effects of polydextrose intake on physiologic functions in Chinese people2000;72(6):1503–1509. Am J Clin Nutr. Link

BACKGROUND: Previous studies showed that polydextrose has physiologic effects similar to those of dietary fiber. OBJECTIVE: Ingestion of 4, 8, and 12 g polydextrose/d was studied to determine the physiologic effects in Chinese subjects. DESIGN: In a placebo-controlled, randomized, double-blind study, we evaluated the effects of polydextrose ingestion on clinical biochemistry indexes, glycated hemoglobin, glucose tolerance, the glycemic index, bowel function, stool weight and pH, short-chain fatty acid production, fecal microflora, and cecal mucosa cell proliferation. RESULTS: Polydextrose had no significant effect on blood biochemistry indexes. Ingestion of 12 g polydextrose plus 50 g glucose resulted in a glycemic index of 89\% (compared with a glycemic index of 100\% after ingestion of 50 g glucose). Bowel function (frequency and ease of defecation) improved significantly and there were no reports of abdominal distention, abdominal cramps, diarrhea, or hypoglycemia.

[2158] Konig D et al. Polydextrose and reduction in postprandial glycaemic response 2012. Nutr J. 2012.

Research paper on polydextrose and the reduction in postprandial glycaemic response.

[2159] Astbury NM et al. Polydextrose results in a dose-dependent reduction in ad libitum energy intake at a subsequent test meal2014;111(8):1499–1505. Br J Nutr. Link

Previous studies have reported that polydextrose can reduce food intake; however, the optimal dose required to achieve this effect is currently unknown. The present study investigated the effects of consuming a range of doses of polydextrose on appetite and energy intake (EI) using a randomised within-subject, cross-over design. For this purpose, twenty-one participants (n 12 men, n 9 women) consumed an 837 kJ liquid preload containing 0 g (control), 6.3, 12.5 or 25 g polydextrose. Subjective appetite ratings were collected using visual analogue scales and an ad libitum test meal was served 90 min later. Participants recorded EI for the remainder of the day in a food diary. Test meal EI following the control preload (5756 (sem 423) kJ) was significantly higher than following the 6.3 g (5048 (sem 384) kJ), 12.5 g (4722 (sem 384) kJ) and 25 g (4362 (sem 316) kJ) preloads (P< 0.05), and EI following the 6.3 g preload was significantly higher than following the 25 g preload (P< 0.01).

[2160] EFSA ANS Panel. Re-evaluation of polydextrose (E 1200) as a food additive2017;15(1):4544. EFSA Journal. Link

EFSA ANS Panel scientific opinion on the re-evaluation of polydextrose (E 1200) as a food additive.

[2161] FDA. 21 CFR 172.841 (food additive) + 21 CFR 101.9 (dietary fiber recognition, 2016). . 2016. Link

FDA regulation: 21 CFR 172.841 (food additive) plus 21 CFR 101.9 (dietary fiber recognition, 2016).